Cvs Health (CVS) Asset Writedowns and Impairment (2022 - 2024)

Cvs Health (CVS) has 3 years of Asset Writedowns and Impairment data on file, last reported at -$840.0 million in Q4 2024.

• For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$840.0 million; the trailing twelve-month figure through Dec 2024 stood at -$233.0 million (down 164.54% YoY), and the FY2023 full-year result was $152.0 million, down 94.0% from the prior year.
• Asset Writedowns and Impairment for Q4 2024 stood at -$840.0 million, down from $607.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $2.5 billion in Q3 2022 and bottomed at -$840.0 million in Q4 2024.
• The 3-year median for Asset Writedowns and Impairment is $195.0 million (2022), against an average of $441.5 million.
• Peak annual rise in Asset Writedowns and Impairment reached 751.22% in 2023, while the deepest fall reached 751.22% in 2023.
• A 3-year view of Asset Writedowns and Impairment shows it stood at $12.0 million in 2022, then surged by 2808.33% to $349.0 million in 2023, then plunged by 340.69% to -$840.0 million in 2024.
• The last three Asset Writedowns and Impairment figures came in at -$840.0 million (Q4 2024), $607.0 million (Q3 2024), and $349.0 million (Q1 2023), per Business Quant data.

Peer Comparison